|
Percentage |
RRaj (CI 95%) |
Percentage |
RRaj (CI 95%) |
Percentage |
RRaj (CI
95%) |
Maternal systemic arterial hypertension a
|
34.4% |
1.0 (0.62; 1.92) |
33.3% |
1.0 (0.53; 2.08) |
22.6% |
0.9 (0.50;
1.91) |
Maternal smoking b
|
15.25% |
1.0 (0.50;2.14) |
13.9% |
0.9 (0.38;2.21) |
17.3% |
0.9 (0.43; 1.93) |
Chorioamnionitis |
17.7% |
0.9 (0.45; 1.75) |
23.2% |
1.2 (0.58; 2.54) |
26.4% |
1.0 (0.55; 1.92) |
Antenatal corticosteroids |
83.6 |
0.7 (0.37; 1.54) |
90.6% |
1.8
(0.63; 5.35) |
79.2% |
1.0 (0.50; 2.08) |
Male |
45.9% |
1.0 (0.61; 1.72) |
46.5% |
1.0 (0.53; 1.82) |
56.6% |
1.2 (0.70; 2.11) |
SGA |
16.3% |
0.7 (0.37; 1.53) |
23.2% |
1.3 (0.63; 2.82) |
20.7% |
1.7 (0.85; 3.54) |
Need for surfactant |
78.3% |
1.8 (0.94; 3.36) |
88.3% |
4.1
(1.59; 10.95) |
81.1% |
1.2 (0.60; 2.57) |
Patent ductus arteriosus |
37.7% |
0.6 (0.38; 1.18) |
65.1% |
2.0 (1.01; 3.99) |
64.1% |
1.6 (0.86; 2.99) |
Early sepsis |
37.7% |
1.1 (0.64; 1.83) |
53.4% |
0.7 (0.38; 1.29) |
83% |
2.7 (1.31; 5.55) |
Late sepsis up to the 14th day of life |
34.4% |
0.9 (0.53; 1.53) |
41.8% |
1.2 (0.63; 2.18) |
32.5% |
1.4 (0.80; 2.41) |
Necrotizing enterocolitis up to the 14th day of life |
8.1% |
0.7
(0.28; 1.80) |
4.6% |
0.4 (0.10; 1.70) |
18.8% |
1.3 (0.66;
2.67) |
FiO2>30% on the 14th day of life c
|
16.6% |
0.4 (0.21; 0.89) |
30.5% |
2.0 (0.97; 4.08) |
51.4% |
3.2 (1.63; 6.26) |
Nasal oxygen catheter |
50% |
3.2 (1.40; 7.53) |
10,7% |
3.3
(0.56; 20.22) |
7.1% |
4.1 (0.37; 45.21) |
CPAP/ NIPPV |
41.2% |
2.5 (1,13; 5,71) |
27.4% |
8.2
(1.82; 36.81) |
15.7% |
7.8 (0.96; 63.14) |
MV |
21.2% |
1.2 (0.48; 3.07) |
29.7% |
8.8 (1.95; 40.16) |
43.7% |
18.2 (2.38; 139.32) |
HFV |
13.0 |
0.7 (0.18; 2.82) |
21.7 |
6.4 (1.17; 35.19) |
60.8 |
24.4 (3.07; 194.14) |